TuisBOT • ASX
add
Botanix Pharmaceuticals Ltd
Vorige sluiting
$0,11
Dagwisseling
$0,11 - $0,13
Jaarwisseling
$0,11 - $0,54
Markkapitalisasie
245,17 m AUD
Gemiddelde volume
7,83 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
ASX
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (AUD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 2,71 m | 219,92% |
Bedryfskoste | 26,90 m | 618,83% |
Netto inkomste | -27,75 m | -560,61% |
Netto winsgrens | -1,03 k | -106,50% |
Wins per aandeel | — | — |
EBITDA | -24,90 m | -492,72% |
Effektiewe belastingkoers | — | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (AUD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 64,97 m | -18,08% |
Totale bates | 129,10 m | 14,79% |
Totale aanspreeklikheid | 47,80 m | 1 180,69% |
Totale ekwiteit | 81,30 m | — |
Uitstaande aandele | 1,96 mjd | — |
Prys om te bespreek | 2,75 | — |
Opbrengs op bates | -49,33% | — |
Opbrengs op kapitaal | -77,17% | — |
Kontantvloei
Netto kontantverandering
| (AUD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | -27,75 m | -560,61% |
Kontant van bedrywe | -24,01 m | -999,67% |
Kontant van beleggings | -97,95 k | 93,92% |
Kontant van finansiering | 32,48 m | -4,95% |
Netto kontantverandering | 8,26 m | -72,90% |
Beskikbare kontantvloei | -9,59 m | -245,54% |
Meer oor
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Gestig
1984
Webwerf
Werknemers
11
